Market News

Larry goldbloom

Weight-loss drug battle: Who are the latest players involved (MRK:NYSE)

Mar. 08, 2025 1:30 PM ETMerck & Co., Inc. (MRK) Stock, LLY Stock, NVS Stock, NVO Stock, AZN Stock, ALT Stock, PFE Stock, ABBV Stock, AMGN Stock, REGN Stock, VKTX Stock, ARWR Stock, VERU Stock, RSLS Stock, RYTM Stock, GPCR Stock, BHVN Stock, SRRK Stock, TERN Stock, KROS Stock, VTYX Stock, ALUR Stock, BIOA Stock, MTSR Stock, RHHBY Stock, ZLDPF Stock, HNSPF StockBy: Tiyashi Datta, SA News Editor
Medicine concept

choi dongsu

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) diving into the opportunity to make effective and targeted anti-obesity products to fulfil the unprecedented demand.

The increase

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

See also  Europe's ETFs Industry Hits Stratospheric Heights with Record Assets Near $2 Trillion

seeking catalyst driven opportunity

we are a small team of three, trying to deliver the best news we think is relevant to traders and investors

© 2024, abovethe200

Contact usabout usPRIVACY POLICYterms of service